Screener / SEC EDGAR /CIK 0001448893 /10-K filed Feb 18, 2026, compared with Feb 19, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Financials · Surety Insurance

Essent Group Ltd. ESNT

Compare with peers Embed
Planned sales, announced before they happen

5 trading plans running, 12 Form 144 notices for $30.0M

10-Q, 10-K and Form 144
Plans running now 5 Mary L. Gibbons, Christopher G. Curran, Roy Kasmar, David Weinstock, Mark Casale
Plans adopted 14 reported since May 10, 2023 Form 144 notices 12 $30.0M the sellers expected to sell

What ESNT's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Mar 11, 2024 to Dec 15, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Mary L. Gibbons
SVP and Chief Legal Officer
Adopted 10b5-1 plan Sep 8, 2026 10-Q Nov 6, 2026
What the company wrote
On September 8, 2026, Mary L. Gibbons, SVP and Chief Legal Officer, entered into a 10b5-1 sales plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the sale of up to an aggregate of 48,367 shares of the Company’s common stock beneficially owned by Ms. Gibbons during the term of the Plan and will be in effect until the earlier of (1) December 15, 2027, and (2) the date on which an aggregate of 48,367 shares of the Company’s common shares have been sold under the Plan.
Christopher G. Curran
President of Essent Guaranty, Inc
Adopted 10b5-1 plan Sep 2, 2026 10-Q Nov 6, 2026
What the company wrote
On September 2, 2026, Christopher G. Curran, President of Essent Guaranty, Inc., entered into a 10b5-1 sales plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the sale of up to an aggregate of 75,000 shares of the Company’s common stock beneficially owned by Mr. Curran during the term of the Plan and will be in effect until the earlier of (1) December 15, 2027, and (2) the date on which an aggregate of 75,000 shares of the Company’s common shares have been sold under the Plan.
Roy Kasmar
board of directors
Adopted 10b5-1 plan Jun 15, 2026 10-Q Aug 7, 2026
What the company wrote
On June 15, 2026, Roy Kasmar, a member of the Company’s board of directors, entered into a 10b5-1 sales plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the sale of up to an aggregate of 2,337 shares of the Company’s common stock beneficially owned by Mr. Kasmar during the term of the Plan and will be in effect until the earlier of (1) June 15, 2027, and (2) the date on which an aggregate of 2,337 shares of the Company’s common shares have been sold under the Plan.
David Weinstock
Company’s Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Mar 10, 2026 10-Q May 8, 2026
Mary Gibbons
Senior Vice President and Chief Legal Officer
Adopted 10b5-1 plan Dec 4, 2025 10-K Feb 18, 2026
What the company wrote
On December 4, 2025, Mary Gibbons, the Company’s Senior Vice President and Chief Legal Officer, entered into a 10b5-1 sales plan (the “Gibbons Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Gibbons Sales Plan provides for the sale of up to an aggregate of 32,038 shares of the Company’s common stock beneficially owned by Ms. Gibbons during the term of the Gibbons Sales Plan and will be in effect until the earlier of (1) August 5, 2026 and (2) the date on which an aggregate of 32,038 shares of the Company’s common stock have been sold under the Gibbons Sales Plan.
Mark Casale
President and Chief Executive Officer
Adopted 10b5-1 plan Nov 24, 2025 10-K Feb 18, 2026
What the company wrote
On November 24, 2025, Mark Casale, the Company’s President and Chief Executive Officer, entered into a 10b5-1 sales plan (the “Casale Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Casale Sales Plan provides for the sale of up to an aggregate of 250,000 shares of the Company’s common stock beneficially owned by Mr. Casale during the term of the Casale Sales Plan and will be in effect until the earlier of (1) February 19, 2027 and (2) the date on which an aggregate of 250,000 shares of the Company’s common stock have been sold under the Casale Sales Plan.
David Weinstock
Company’s Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan Mar 10, 2025 10-Q May 9, 2025
What the company wrote
On March 10, 2025, David Weinstock, the Company’s Senior Vice President and Chief Financial Officer, entered into a 10b5-1 sales plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the sale of up to an aggregate of 5,000 shares of the Company’s common stock beneficially owned by Mr. Weinstock during the term of the Plan and will be in effect until the earlier of (1) June 12, 2026, and (2) the date on which an aggregate of 5,000 shares of the Company’s common stock have been sold under the Plan.
Mary Gibbons
Senior Vice President and Chief Legal Officer
Adopted 10b5-1 plan Dec 14, 2024 10-K Feb 19, 2025
What the company wrote
On December 14, 2024, Mary Gibbons, the Company’s Senior Vice President and Chief Legal Officer, entered into a 10b5-1 sales plan (the “Gibbons Sales Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Gibbons Sales Plan provides for the sale of up to an aggregate of 26,610 shares of the Company’s common stock beneficially owned by Ms. Gibbons during the term of the Gibbons Sales Plan and will be in effect until the earlier of (1) December 31, 2025 and (2) the date on which an aggregate of 26,610 shares of the Company’s common stock have been sold under the Gibbons Sales Plan.
Mark Casale
President and Chief Executive Officer
Adopted 10b5-1 plan Sep 5, 2024 10-Q Nov 5, 2024
What the company wrote
On September 5, 2024, Mark Casale, the Company’s President and Chief Executive Officer, entered into a 10b5-1 sales plan (the “Casale Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Casale Plan provides for the sale of up to an aggregate of 250,000 shares of the Company’s common stock beneficially owned by Mr. Casale during the term of the Casale Plan and will be in effect until the earlier of (1) December 5, 2025 and (2) the date on which an aggregate of 250,000 shares of the Company’s common stock have been sold under the Casale Plan.
David Weinstock
Senior Vice President and Chief Financial Office
Adopted 10b5-1 plan Mar 11, 2024 10-Q May 7, 2024
What the company wrote
On March 11, 2024, David Weinstock, the Company’s Senior Vice President and Chief Financial Officer, entered into a 10b5-1 sales plan (the “Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Plan provides for the sale of up to an aggregate of 4,000 shares of the Company’s common stock beneficially owned by Mr. Weinstock during the term of the Plan and will be in effect until the earlier of (1) February 8, 2025 and (2) the date on which an aggregate of 4,000 shares of the Company’s common stock have been sold under the Plan.
Mary Gibbons
Senior Vice President and Chief Legal Officer
Adopted 10b5-1 plan May 23, 2023 10-Q Aug 8, 2023
David Weinstock
Senior Vice President and Chief Financial Officer
Adopted 10b5-1 plan May 15, 2023 10-Q Aug 8, 2023
Mark Casale
President and Chief Executive Officer
Adopted plan – 10-K Feb 19, 2025
What the company wrote
On September 5, 2024, Mark Casale, the Company’s President and Chief Executive Officer, entered into a 10b5-1 sales plan (the “Casale Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. On December 2. 2024, Mr. Casale terminated the Casale Plan in its entirety. No shares were sold under the Casale Plan prior to its termination.
Vijay Bhasin
Senior Vice President and Chief Risk Officer
Adopted 10b5-1 plan – 10-Q Nov 5, 2024
What the company wrote
On August 30, 2024, Vijay Bhasin, the Company’s Senior Vice President and Chief Risk Officer, entered into a 10b5-1 sales plan (the “Bhasin Plan”) intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Bhasin Plan provides for the sale of up to an aggregate of 122,449 shares of the Company’s common stock beneficially owned by Mr. Bhasin during the term of the Bhasin Plan and will be in effect until the earlier of (1) August 30, 2026 and (2) the date on which an aggregate of 122,449 shares of the Company’s common stock have been sold under the Bhasin Plan.
Show the other 6 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Sep 14, 2026 KASMAR ROY JAMES
Director
2,500 $172K
Sep 14, 2026 KASMAR ROY JAMES
Director
2,337 $161K
Aug 24, 2026 PAULS DOUGLAS J
Director
2,500 $172K
Aug 18, 2026 Mark Casale
Chairman, CEO, President
100,000 $6.9M
Aug 18, 2026 Bhasin Vijay
Officer
14,175 $992K
Aug 7, 2026 Bhasin Vijay
Officer
483 $34K
Jul 17, 2026 Gibbons Mary Lourdes
Officer
19,288 $1.4M
Jun 26, 2026 WEINSTOCK DAVID B
Officer
11,000 $708K
Apr 28, 2026 Mark Casale
Chairman, CEO, President
250,000 $16.1M
Apr 17, 2026 Gibbons Mary Lourdes
Officer
32,038 $2.2M
Dec 18, 2025 Gibbons Mary Lourdes
Officer
14,610 $1.0M
Nov 14, 2025 KASMAR ROY JAMES
Director
3,250 $200K
Show the other 4 notices

From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/ESNT/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.